College of Psychiatric and Neurologic Pharmacists

Increase access to treatment for mental illness, substance abuse and neurological disorder

Based in NE

🤖

AI Overview

With $320K in lobbying spend across 17 quarterly filings, College of Psychiatric and Neurologic Pharmacists is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2022.

$320K
Total Spend
5
Years Active
1
Firms Hired
4
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$80K
2019$80K
2020$80K
2021$80K
2022$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Budget/Appropriations

  • HR 592/ S. 109, Pharmacy and Medically Underserved Areas Enhancement Act.
  • Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act;
  • FY 2018 Appropriations (Consolidated Appropriation Act) related to health professions (HRSA Title VII) and opioids; FY 19 appropriation (LHHS) related to health professions (HRSA Title VII) and opioid
  • Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Cri
  • HR 592/ S. 109, Pharmacy and Medically Under-served Areas Enhancement Act; Letter to Sec. Azar regarding Part D's six protected classes.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.